Edetic Acid

Edetic Acid

SCHEMBL29967837

O.O.O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O.[Na].[Na]

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Edetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE known ✓ P12821 1/20 0.88
▸ CHRM2 known ✓ P08172 1/20 0.82
▸ ADRA2A known ✓ P08913 1/20 0.82
▸ SLC6A2 known ✓ P23975 1/20 0.82
▸ SLC6A4 known ✓ P31645 1/20 0.82
▸ ADRA1A known ✓ P35348 1/20 0.82
▸ DRD3 known ✓ P35462 1/20 0.82
▸ SLC6A3 known ✓ Q01959 1/20 0.82
▸ TDP1 Q9NUW8 2/20 0.88
▸ EYA2 O00167 1/20 0.88
▸ APP P05067 1/20 0.88
▸ BLM P54132 2/20 0.82
▸ PMP22 Q01453 2/20 0.82
▸ KDM4E B2RXH2 1/20 0.82
▸ LMNA P02545 1/20 0.82
▸ ALOX15 P16050 1/20 0.82
▸ TSHR P16473 1/20 0.82
▸ DRD1 P21728 1/20 0.82
▸ CYP2C19 P33261 1/20 0.82
▸ HRH3 Q9Y5N1 1/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Edetic Acid SCHEMBL17416909 1.00 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL8374506 1.00 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL9621416 1.00 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL9014503 1.00 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL6932335 1.00 TDP1 (0.88) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL31139623 0.97 TDP1 (0.82) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL10542859 0.97 TDP1 (0.93) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL464945 0.97 TDP1 (0.93) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL731870 0.97 TDP1 (0.93) TDP1EYA2APPACEBLM
Edetic Acid SCHEMBL11181102 0.97 TDP1 (0.93) TDP1EYA2APPACEBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081372-A1 PROCESSES FOR THE PREPARATION OF THE AGENT-LINKER CONJUGATE CL2A-SN-38 AND THE IMMUNOCONJUGATES SACITUZUMAB GOVITECAN AND LABETUZUMAB GOVETICAN GILEAD SCIENCES, INC. (US) 2024-04-18 — — WO disclosed
US-11471512-B2 Pharmaceutical compositions of a peptide MERCK SHARP & DOHME LLC (US) 2022-10-18 — — US disclosed
WO-2022190737-A1 METHOD AND DEVICE FOR MEASURING TDP-43 IN BIOLOGICAL SAMPLE 国立研究開発法人量子科学技術研究開発機構 2022-09-15 — — WO disclosed
Send feedback